您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

劉建衛醫師

感染症、臨床微生物學、內科相關疾病、醫院感染控制、感染症流行病學
  • 國語,英語,閩南語
  • 教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 長庚大學部定教授
    • 顧問級主治醫師
    • 衛生福利部傳染病防治醫療網高屏區副指揮官
  • 學歷
    • 中山醫學大學醫學系
  • 經歷
    • 國立成功大學醫學院附設醫院內科住院醫師
    • 國立成功大學醫學院附設醫院感染科研究員
    • 高雄長庚紀念醫院感染醫學科主治醫師
    • 長庚大學醫學院內科講師、助理教授、副教授、教授
    • 高雄長庚紀念醫院臨床病理科微生物檢驗室臨床主任 (Medical Director) (2007-2009)
    • 高雄長庚紀念醫院感染科科主任 (1999.07-2009.06; 2015.07-2017.06)
    • 高雄長庚紀念醫院內科部主任 (2009-2013)
  • 學會與認證
    • 台灣感染管制學會會員
    • 台灣感染症醫學會會員
    • 台灣內科醫學會會員
  • 論文及期刊發表
    • @@@@@ SELECTED PUBLICATIONS [*Corresponding Author] @@@@@

    • JW Liu*, NY Hsu, TC Huang. Pustules and bacteraemia. Lancet 1997; 350: 860.

    • JW Liu, JJ Wu, HM Chen, AH Huang, et al. Methylobacterium mesophilicum synovitis in an alcoholic. Clinical Infectious Diseases 1997; 24: 1008-1009.

    • JW Liu, B Lee, WC Ko, YC Chuang. Hemorrhagic fever with renal syndrome: First imported case of hantavirus infection in Taiwan. Journal of the Formosan Medical Association 1996; 95: 480-483.

    • YC Chuang, JW Liu, WC Ko, et al. In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrobial Agents & Chemotherapy 1997; 41: 2214-2217.

    • YC Chuang, WC Ko, ST Wang, JW Liu, et al. Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrobial Agents & Chemotherapy 1998; 42: 1319-1322.

    • PR Hsueh, CY Lin, HJ Tang, HC Lee, JW Liu, et al. Vibrio vulnificus in Taiwan. Emerging Infectious Diseases 2004; 10:1361-1368.

    • JW Liu, IK Lee, HJ Tang, et al. Prognostic factors and antibiotics in Vibrio vulnificus septicemia. Archives of Internal Medicine (currently known as JAMA Internal Medicine) 2006; 166: 2117-2123.

    • JW Liu*, YK Su, CF Liu, JB Chen: Nosocomial blood-stream infection in patients with end-stage renal disease: Excess length of hospital stay, extra cost, and attributable mortality. Journal of Hospital Infection 2002; 50: 224-227.

    • JW Liu*, LH Chao, LH Su, JW Wang, CJ Wang. Experience with a bone bank operation and allograft bone infection in recipients at a medical center in southern Taiwan. Journal of Hospital Infection 2002; 50: 293-297.

    • JW Liu*, YM Hsu, YF Huang: Independent prognostic factors for fatality in patients with urinary tract infection caused by Serratia marcescens. Infection Control & Hospital Epidemiology 2004; 25: 80-82.

    • CH Lee, YF Tang, JW Liu*. Underdiagnosis of urinary tract infection caused by Methylobacterium species with current standard processing urine culture and its clinical implications. Journal of Medical Microbiology 2004; 53: 755-759.

    • KH Lin, JW Liu**, CL Chen, SH Wang, CC Lin, YW Liu, CC Yong, TL Lin, WF Li, TH Hu, CC Wang*. Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation. PLoS One 2013; 8: e72893. (** Co-first author)

    • IL Chen, CH Lee, LH Su, YF Tang, SJ Chang, JW Liu*. Antibiotic consumption and healthcare-associated infections caused by multidrug-resistant Gram-negative bacilli at a large medical center in Taiwan from 2002 to 2009: implicating the importance of antibiotic stewardship. PLoS One 2013; 8: e65621.

    • LH Su, IL Chen, YF Tang, JS Lee, JW Liu*. Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study. PLoS One 2020: 15: e0233265.

    • JW Liu, SN Lu, SS Chen, KD Yang, et al. Epidemiologic study and containment of a nosocomial outbreak of severe acute respiratory syndrome in a medical center in Kaohsiung, Taiwan. Infection Control & Hospital Epidemiology 2006; 27: 466-472.

    • MS Tsai, JW Liu*, WS Chen, de Villa VH: Tuberculous wrist in the effective chemotherapy era: an eleven-year experience. International Journal of Tuberculosis & Lung Disease 2003; 7: 690-694.

    • SF Liu, JW Liu*, MC Lin. Characteristics of patients suffering from tuberculous pleuritis with pleural effusion culture positive and negative for Mycobacterium tuberculosis, and risk factors for fatality. International Journal of Tuberculosis & Lung Disease 2005; 9: 111-115.

    • IK Lee, JW Liu*. Tuberculous parotitis: Case report and literature review. Annals of Otology, Rhinology & Laryngology 2005; 114: 547-551.

    • IK Lee, WC Yang, JW Liu*. Scrotal tuberculosis in adult patients: A 10-year clinical experience. American Journal of Tropical Medicine & Hygiene 2007; 77: 714-718.

    • SF Liu, JW Liu*, MC Lin, CH Lee, HH Huang, YF Lai. Monitoring treatment responses in patients with pulmonary TB using serial lung gallium-67 scintigraphy. American Journal of Roentgenology 2007; 188: W403-408.

    • CH Lee, CC Lui, JW Liu*: Immune reconstitution syndrome in an AIDS patient with paradoxically deteriorating brain tuberculoma. AIDS Patient Care & STDs 2007; 21: 234-239.

    • TL Lin, SY Chi, JW Liu*, FF Chou*. Tuberculosis of the breast: 10 years’ experience in one institution. International Journal of Tuberculosis & Lung Disease 2010; 14: 758-763.

    • CH Lee, HL You, JW Wang, YF Tang, JW Liu*. Prosthetic joint infection caused by Mycobacterium alvei in an elderly patient. Journal of Clinical Microbiology 2011; 49: 396-398.

    • JW Liu, BS Khor, CH Lee, IK Lee, RF Chen, KD Yang: Dengue hemorrhagic fever in Taiwan. Dengue Bulletin 2003: 27: 19-24.

    • IK Lee, JW Liu*, KD Yang. Clinical characteristics and risk factors for concurrent bacteremia in patients with dengue hemorrhagic fever. American Journal of Tropical Medicine & Hygiene 2005; 72: 221-226.

    • RF Chen, JW Liu, WT Yeh, L Wang, JC Chang, HR Yu, JT Cheng, KD Yang. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunology & Medical Microbiology 2005; 44: 43-50.

    • BS Khor, JW Liu*, IK Lee, KD Yang. Dengue hemorrhagic fever patients presenting with acute abdomen: experience of 14 cases. American Journal of Tropical Medicine & Hygiene 2006; 74:901-904.

    • L Wang, RF Chen, JW Liu, HR Yu, HC Kuo, KD Yang. Implications of dynamic changes amongst TNFα, membrane TNF receptor and soluble TNF receptor levels in regard to the severity of dengue infection. American Journal of Tropical Medicine & Hygiene 2007; 77: 297-302.

    • IK Lee, JW Liu*, KD Yang. Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever. American Journal of Tropical Medicine & Hygiene 2008; 79: 149-153.

    • IK Lee, JW Liu*, KD Yang. Clinical characteristics, risk factor and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure. American Journal of Tropical Medicine & Hygiene 2009; 80: 651-655.

    • IK Lee, WH Lee, KD Yang, JW Liu*. Comparison of the effects of oral hydration and intravenous fluid replacement in adult patients with non-shock dengue hemorrhagic fever in Taiwan. Transactions of the Royal Society of Tropical Medicine & Hygiene 2010; 104: 541-545.

    • IK Lee, WH Lee, JW Liu*, KD Yang. Acute myocarditis in dengue hemorrhagic fever: a case report and review of cardiac complications in dengue-affected patients. International Journal of Infectious Diseases 2010; 14: e919-e922.

    • IK Lee, JW Liu*, KD Yang. Fatal dengue hemorrhagic fever in adults: emphasizing the evolutionary pre-fatal clinical and laboratory manifestations. PLoS Neglected Tropical Diseases 2012; 6 (2): e1532.

    • CY Tsai, IK Lee, CH Lee, KD Yang, JW Liu*. Comparisons of dengue illness classified based on the 1997 and 2009 World Health Organization dengue classification schemes. Journal of Microbiology, Immunology & Infection 2013: 46: 271-281.

    • JW Liu*, IK Lee, L Wang, RF Chen, KD Yang. The usefulness of clinical-practice-based laboratory data in facilitating the diagnosis of dengue illness. BioMed Research International 2013; Article ID 198797, 11 pages.

    • IK Lee, CJ Hsieh, RF Chen, JW Liu*, et al. Increased production of interleukin-4, interleukin-10 and granulocyte-macrophage colony-stimulating factor by type 2 diabetes’mononuclear cells infected with dengue virus, but not increased intracellular viral multiplication. BioMed Research International 2013; Article ID 965853, 7 pages.

    • HJ Kuo, IK Lee*, JW Liu*. Laboratory characteristics of dengue adults at their hospital presentations based on the World Health Organization clinical-phase framework: Emphasizing risk of severe dengue in the elderly. Journal of Microbiology, Immunology & Infection 2018; 51: 740-748.

    • IK Lee, CJ Hsieh, CT Lee, JW Liu*. Diabetic patients suffering dengue are at risk for development of dengue shock syndrome/severe dengue: Emphasizing the impacts of co-existing comorbidity(ies) and glycemic control on dengue severity. Journal of Microbiology, Immunology & Infection 2020; 53: 69-78.

    • CH Lee, LH Su, YF Tang, JW Liu*. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: A retrospective study and laboratory analysis of the isolates. Journal of Antimicrobial Chemotherapy 2006; 58: 1074-1077.

    • JW Liu, LS Wang, YJ Cheng, et al. In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan. International Journal of Antimicrobial Agents 2008; 32 (Supplement 2): S188-S191.

    • CH Lee, YF Tang, LH Su, CC Chien, JW Liu*. Antimicrobial effects of varied combinations of meropenem, sulbactam and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia. Microbial Drug Resistance 2008; 14: 233-237.

    • CH Lee, LH Su, CC Li, CC Chien, YF Tang, JW Liu*. Microbiologic and clinical implications of bacteremia due to extended-spectrum β-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC β-lactamase (DHA-1). Antimicrobial Agents & Chemotherapy 2010; 54:5395-5398.

    • JW Liu , WC Ko, CH Huang, et al. Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In-vitro Surveillance in Taiwan [TIST] Study, 2008-2010. Antimicrobial Agents & Chemotherapy 2012: 56; 1414-1417.

    • CH Lee, CY Tsai, CC Li, CC Chien, JW Liu*. Teicoplanin therapy for MRSA bacteraemia: A retrospective study emphasizing the importance of maintenance dosing in improving clinical outcomes. Journal of Antimicrobial Chemotherapy 2015; 70: 257-263.

    • JW Liu, YH Chen, WS Lee, et al. Randomized noninferiority trial of cefoperazone-sulbactam versus cefepime in the treatment of hospital-acquired and healthcare-associated pneumonia. Antimicrobial Agents & Chemotherapy 2019; 63(8): e00023-19.

    • JW Liu, YH Chen, WS Lee, et al. Reply to Zhou and Wu, "Be careful with adverse events caused by cefoperazone-sulbactam". Antimicrobial Agents & Chemotherapy 2020; 64: e02028-19. (Letter)

    • YF Tang, YS Lin, LH Su, JW Liu*. Increasing trend of healthcare-associated infections due to vancomycin-resistant Enterococcus faecium (VRE-fm) paralleling escalating community-acquired VRE-fm infections in a medical center implementing strict contact precautions: An epidemiologic and pathogenic genotype analysis and its implications. Journal of Microbiology, Immunology & Infection 2023; 56: 1045-1053.